Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Medical Affairs Seminar - Launching a High-Value Medical & Scientific Affairs Team

22 Jan 2013 - 23 Jan 2013 - Boston, MA, USA



Bookmark and Share


Medical Affairs Seminar - Launching A High-Value Medical & Scientific Affairs Team

During the past decade, Medical Affairs has become a critical function within all pharmaceutical and biotechnology companies. A high-performance Medical Affairs team will not only support but drive the safe, effective and appropriate use of medications throughout a product lifecycle. A Medical Affairs Department is now a necessity rather than a luxury. 

Launching a High Value Medical Affairs Team is an interactive learning opportunity for professionals who are setting up, expanding or restructuring Medical Affairs Departments and Groups. This program will help participants identify the needs of their organization, the appropriate structure and organizational alignment and identify critical functions, and will clarify many other operational aspects that are key to building a sustainable and respected department.

This conference will offer an opportunity to learn from others who have built Medical Affairs teams from the ground up, including the good, the bad and the ugly. Finally, and most important, the seminar is an excellent opportunity to pause from everyday duties, in order to reflect on your medical affairs strategies and tactics, and exchange experiences through networking and discussion with your peers.



Further information
Scientific News
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Zika Vaccine Testing in Humans
The NAAID has initiated a clinical trail of a vaccine candidate for the prevention of the Zika virus infection.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!